Role of Salivary Biomarkers in Cystic Fibrosis: A Systematic Review
- PMID: 35097122
- PMCID: PMC8791744
- DOI: 10.1155/2022/5818840
Role of Salivary Biomarkers in Cystic Fibrosis: A Systematic Review
Abstract
Background: Saliva biomarkers could be easily used as a noninvasive alternative tool for diagnosing cystic fibrosis (CF) disease. In this study, the significance of changes in salivary compositions in patients with CF was systematically reviewed.
Methods: An electronic search was utilized to include studies published in English, with case-control, cohort, or cross-sectional design. The evaluated salivary components were extracted and summarized. The included studies were assessed using the Strengthening the Reporting of Observational Studies in Epidemiology checklist.
Results: Out of 498 identified studies, nine met the eligibility criteria. Salivary electrolytes showed a substantial alteration in the CF group, especially with chloride and sodium. Total protein concentration was higher in patients with CF. However, SCN- concentration was lower in patients with CF. In addition, a reduction in the salivary flow rate and amylase levels was found in patients with CF.
Conclusion: Alterations in salivary biomarkers among patients with CF could be used as a promising diagnostic tool for cystic fibrosis.
Copyright © 2022 Asma Almeslet et al.
Conflict of interest statement
The authors declare no conflict of interests.
Figures
Similar articles
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
-
Exercise versus airway clearance techniques for people with cystic fibrosis.Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2. Cochrane Database Syst Rev. 2022. PMID: 35731672 Free PMC article.
-
Nebulised hypertonic saline for cystic fibrosis.Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Jun 14;6:CD001506. doi: 10.1002/14651858.CD001506.pub5. PMID: 30260472 Free PMC article. Updated.
-
Autogenic drainage for airway clearance in cystic fibrosis.Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD009595. doi: 10.1002/14651858.CD009595.pub3. Cochrane Database Syst Rev. 2021. PMID: 34910295 Free PMC article.
-
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD012619. doi: 10.1002/14651858.CD012619.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Dec 22;12:CD012619. doi: 10.1002/14651858.CD012619.pub3. PMID: 29894558 Free PMC article. Updated.
Cited by
-
Evaluation of Salivary Diagnostics: Applications, Benefits, Challenges, and Future Prospects in Dental and Systemic Disease Detection.Cureus. 2025 Jan 16;17(1):e77520. doi: 10.7759/cureus.77520. eCollection 2025 Jan. Cureus. 2025. PMID: 39958008 Free PMC article. Review.
-
Oral health in individuals with cystic fibrosis: A cross-sectional study.Heliyon. 2024 Feb 1;10(3):e25241. doi: 10.1016/j.heliyon.2024.e25241. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356573 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous